Watchlist
Loading...
HK Stock MarketDetailed Quotes

02616 CSTONE PHARMA-B

Watchlist
2.250 -0.040-1.75%
Not Open 11/29 16:08 CST
2.320High2.230Low3.56MVolume

CSTONE PHARMA-B Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)2023/06/30
(FY)2022/12/31
(Q6)2022/06/30
(FY)2021/12/31
(Q6)2021/06/30
(FY)2020/12/31
(Q6)2020/06/30
(FY)2019/12/31
(Q6)2019/06/30
(FY)2018/12/31
Turnover
-0.11%261.47M
97.51%481.36M
229.48%261.77M
-76.54%243.72M
--79.45M
--1.04B
----
----
----
----
Operating income
-0.11%261.47M
97.51%481.36M
229.48%261.77M
-76.54%243.72M
79.45M
1.04B
Cost of sales
-16.52%-108.04M
-90.00%-202.99M
-197.05%-92.72M
55.75%-106.83M
---31.22M
---241.42M
----
----
----
----
Operating expenses
-16.52%-108.04M
-90.00%-202.99M
-197.05%-92.72M
55.75%-106.83M
-31.22M
-241.42M
Gross profit
-9.23%153.44M
103.36%278.38M
250.46%169.04M
-82.83%136.89M
48.23M
797.41M
Selling expenses
10.19%-131.45M
10.03%-327.3M
-9.56%-146.35M
-155.92%-363.79M
-455.33%-133.58M
---142.15M
---24.06M
----
----
----
Administrative expenses
33.84%-89.19M
16.31%-249.06M
12.52%-134.82M
13.11%-297.6M
6.73%-154.11M
-0.30%-342.51M
1.55%-165.23M
-78.79%-341.48M
-350.00%-167.84M
-385.55%-190.99M
Research and development expenses
29.95%-186.77M
52.94%-614.16M
48.00%-266.63M
7.10%-1.3B
5.77%-512.75M
-0.65%-1.4B
-41.87%-544.15M
-64.15%-1.4B
24.61%-383.56M
-298.33%-850.2M
Special items of operating profit
151.54%50.62M
120.30%17.95M
203.48%20.12M
30.79%-88.42M
-131.15%-19.45M
77.63%-127.75M
109.12%62.43M
24.06%-571.04M
-245.18%-684.25M
-738.18%-751.94M
Operating profit
43.30%-203.35M
53.38%-894.2M
53.52%-358.63M
-57.24%-1.92B
-15.00%-771.65M
47.16%-1.22B
45.70%-671.01M
-28.72%-2.31B
-66.02%-1.24B
-423.56%-1.79B
Financing cost
-100.07%-5.87M
-278.10%-8.48M
-33.64%-2.94M
-69.85%-2.24M
-823.11%-2.2M
-335.64%-1.32M
-59.73%-238K
---303K
---149K
----
Earning before tax
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-28.74%-2.31B
-66.04%-1.24B
-423.47%-1.79B
After-tax profit from continuing operations
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-28.74%-2.31B
-66.04%-1.24B
-423.47%-1.79B
Earning after tax
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-28.74%-2.31B
-66.04%-1.24B
-423.47%-1.79B
Minority profit
----
----
----
----
----
----
----
----
----
-42.23%-47.85M
Profit attributable to shareholders
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-32.27%-2.31B
-72.20%-1.24B
-464.99%-1.75B
Basic earnings per share
45.16%-0.17
53.33%-0.77
53.73%-0.31
-41.03%-1.65
-1.52%-0.67
51.05%-1.17
-148.89%-0.66
14.34%-2.39
199.26%1.35
-316.42%-2.79
Diluted earnings per share
45.16%-0.17
53.33%-0.77
53.73%-0.31
-41.03%-1.65
-1.52%-0.67
51.05%-1.17
-148.89%-0.66
14.34%-2.39
199.26%1.35
-316.42%-2.79
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
(Q6)2023/06/30(FY)2022/12/31(Q6)2022/06/30(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30(FY)2019/12/31(Q6)2019/06/30(FY)2018/12/31
Turnover -0.11%261.47M97.51%481.36M229.48%261.77M-76.54%243.72M--79.45M--1.04B----------------
Operating income -0.11%261.47M97.51%481.36M229.48%261.77M-76.54%243.72M79.45M1.04B
Cost of sales -16.52%-108.04M-90.00%-202.99M-197.05%-92.72M55.75%-106.83M---31.22M---241.42M----------------
Operating expenses -16.52%-108.04M-90.00%-202.99M-197.05%-92.72M55.75%-106.83M-31.22M-241.42M
Gross profit -9.23%153.44M103.36%278.38M250.46%169.04M-82.83%136.89M48.23M797.41M
Selling expenses 10.19%-131.45M10.03%-327.3M-9.56%-146.35M-155.92%-363.79M-455.33%-133.58M---142.15M---24.06M------------
Administrative expenses 33.84%-89.19M16.31%-249.06M12.52%-134.82M13.11%-297.6M6.73%-154.11M-0.30%-342.51M1.55%-165.23M-78.79%-341.48M-350.00%-167.84M-385.55%-190.99M
Research and development expenses 29.95%-186.77M52.94%-614.16M48.00%-266.63M7.10%-1.3B5.77%-512.75M-0.65%-1.4B-41.87%-544.15M-64.15%-1.4B24.61%-383.56M-298.33%-850.2M
Special items of operating profit 151.54%50.62M120.30%17.95M203.48%20.12M30.79%-88.42M-131.15%-19.45M77.63%-127.75M109.12%62.43M24.06%-571.04M-245.18%-684.25M-738.18%-751.94M
Operating profit 43.30%-203.35M53.38%-894.2M53.52%-358.63M-57.24%-1.92B-15.00%-771.65M47.16%-1.22B45.70%-671.01M-28.72%-2.31B-66.02%-1.24B-423.56%-1.79B
Financing cost -100.07%-5.87M-278.10%-8.48M-33.64%-2.94M-69.85%-2.24M-823.11%-2.2M-335.64%-1.32M-59.73%-238K---303K---149K----
Earning before tax 42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-28.74%-2.31B-66.04%-1.24B-423.47%-1.79B
After-tax profit from continuing operations 42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-28.74%-2.31B-66.04%-1.24B-423.47%-1.79B
Earning after tax 42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-28.74%-2.31B-66.04%-1.24B-423.47%-1.79B
Minority profit -------------------------------------42.23%-47.85M
Profit attributable to shareholders 42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-32.27%-2.31B-72.20%-1.24B-464.99%-1.75B
Basic earnings per share 45.16%-0.1753.33%-0.7753.73%-0.31-41.03%-1.65-1.52%-0.6751.05%-1.17-148.89%-0.6614.34%-2.39199.26%1.35-316.42%-2.79
Diluted earnings per share 45.16%-0.1753.33%-0.7753.73%-0.31-41.03%-1.65-1.52%-0.6751.05%-1.17-148.89%-0.6614.34%-2.39199.26%1.35-316.42%-2.79
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >